Numerous factors, including rising demand for liquid chromatography instruments in the pharma & bio, and public sectors, can be credited for the growth of the liquid chromatography instruments market. Additionally, developments in technology and a rising interest in liquid chromatography are fuelling this market's expansion globally. The market for liquid chromatography instruments is also expanding as a result of rising environmental concerns, a rise in pharmaceutical and biotechnology demand, and the introduction of innovative technologies including cloud-based systems.
Throughout the projected period, demand for liquid chromatography instruments is anticipated to increase significantly. The increased prevalence of diseases and the growing demand for sophisticated analytical methods and technologies for medical research, clinical diagnosis, and food testing are both responsible for this expansion. Big data analytics and the rising importance of tailored healthcare solutions have both contributed to the increased use of liquid chromatography equipment.
The market for liquid chromatography devices benefits from this technology's improved efficiency, precision, and speed compared to conventional chemical analysis methods. Additionally, it offers increased selectivity, repeatability, sample throughput, sensitivity, and resolution. Additionally, it is the best option for many applications due to its capacity to separate, detect, and quantify minuscule quantities of chemicals in complicated mixtures.
A liquid mobile phase is used in liquid chromatography (LC), a type of chromatography that separates the constituents of a mixture using this method. For analysis and purification reasons, this approach is frequently utilised in the chemical, pharmaceutical, and biotechnology sectors of the economy. Today's market offers a wide selection of liquid chromatography equipment, all of which are created to satisfy the requirements of various applications.
At a CAGR of 10.5% during the forecast period, the market for liquid chromatography instruments is anticipated to increase from USD 7.8 billion in 2021 to USD 15.5 billion by 2031.
.png)
The rising demand for liquid chromatography instruments in the pharma & bio and public sectors is responsible for the expansion of this market.
There are some reasons that hinder the growth of the liquid chromatography instrument market. These include the expensive cost of the equipment, the shortage of skilled workers, and the insufficient supply of consumables needed to operate chromatographic systems. Many end customers are unable to utilise liquid chromatography equipment due to its complexity. However, manufacturers are working to simplify the operating difficulties of liquid chromatography instruments as a result of technological developments, which is anticipated to encourage its adoption. Additionally, over the course of the forecast period, the development of portable and miniaturised LC systems is anticipated to spur market expansion.
Agilent Technologies, Thermo Fisher Scientific, Shimadzu Corporation, Waters Corporation, HTG Molecular Diagnostics Inc., Bio-Rad Laboratories Inc., PerkinElmer Inc., Bruker Corporation, Becton Dickinson & Company, and Merck KGaA are some of the major players in the liquid chromatography instruments market.
Segment Analysis
The High-Performance Liquid Chromatography Type to Emerge as the Most Lucrative Segment
High Performance Liquid Chromatography is anticipated to dominate the market for liquid chromatography devices in 2021. (HPLC). Applications for HPLC systems include food testing, environmental monitoring, drug discovery and development, and other industrial uses. The development of new technology has made HPLC systems more dependable and efficient. Ultra-High-Pressure Liquid Chromatography (UHPLC), which provides greater performance in difficult analytical applications such chiral separations and preparative chromatography, is the next-largest market. UHPLC systems also enable quicker analytical times and have a higher resolution than HPLC systems. Other types of liquid chromatography equipment, such as low-pressure liquid chromatography (LPLC), are also gaining popularity.
The Most Popular Application Segment is Pharma & Bio
According to estimates, the largest application market for liquid chromatography equipment is the pharmaceutical and biomedical sector. The need for LC systems in this industry is being driven by the rising demand for effective drug development procedures and high precision in bio-molecular research. Additionally, due to the rising demand for food safety and drug testing, the public sector is anticipated to have substantial growth in the liquid chromatography instruments market. Due to its uses in chemical processing, water quality monitoring, and other industries, the industrial segment is also anticipated to rise significantly during the forecast period.
North American region to render Adequate Financing Avenues
Due to the existence of numerous major companies and an excellent technological infrastructure, North America is predicted to be the market's most lucrative regional segment for liquid chromatography equipment. The need for liquid chromatography systems is anticipated to increase significantly in European nations including Germany, France, and the UK. Due to the growing number of pharmaceutical and biotechnology enterprises in nations like India, China, and Japan, the Asia Pacific area is predicted to be a lucrative market for liquid chromatography equipment.
COVID-19 Impact and Market Status
The global market for liquid chromatographic equipment has been significantly impacted by the Covid-19 epidemic. Market growth has slowed as a result of the disturbance to the demand and supply chains. Despite this, the market is anticipated to rebound in 2021 and continue to develop steadily between 2021 and 2031. Additionally, it is anticipated that government programmes to assist industrial growth, private and public investments, and an increased emphasis on R&D would be major market drivers.
Latest Innovations in the Global Liquid Chromatography Instruments Market: A Snapshot
• To increase its Ultra High Performance Liquid Chromatography (UHPLC) product line and better serve its market clients, Waters Corporation purchased ACQUITY Group Ltd. in April 2019.
• For the development and production of robotic automated liquid chromatography instruments for the biopharmaceutical sector, GBC Scientific Equipment has partnered with Chrom Tech Inc.
Liquid Chromatography Instruments Market Scope
| Metrics | Details |
| Base Year | 2023 |
| Historic Data | 2018-2022 |
| Forecast Period | 2024-2031 |
| Study Period | 2018-2031 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2031 | USD 15.5 billion |
| Growth Rate | CAGR of 10.5% during 2021-2031 |
| Segment Covered | by Type, By Application, Regions |
| Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
| Key Players Profiled | Agilent Technologies, Thermo Fisher Scientific, Shimadzu Corporation, Waters Corporation, HTG Molecular Diagnostics Inc., Bio-Rad Laboratories Inc., PerkinElmer Inc., Bruker Corporation, Becton Dickinson & Company, and Merck KGaA |
Key Segments of the Liquid Chromatography Instruments
by Type Overview (USD Billion)
• High Performance Liquid Chromatography (HPLC)
• Ultra High-Pressure Liquid Chromatography (UHPLC)
• Low Pressure Liquid Chromatography (LPLC)
• Others
By Application Overview (USD Billion)
• Pharma & Bio
• Public
• Industry
• Others
Regional Overview (USD Billion)
North America
• U.S
• Canada
Europe
• Germany
• France
• UK
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Rest of Asia Pacific
South America
• Mexico
• Brazil
• Rest of South America
Middle East and Africa
Frequently Asked Questions (FAQ) :
The global Liquid Chromatography Instruments market size is expected to reach USD 15.5 billion in 2031.
The Liquid Chromatography Instruments market is estimated to grow at a CAGR of 10.5% during 2021-2031
Key companies covered in the Liquid Chromatography Instruments market are Agilent Technologies, Thermo Fisher Scientific, Shimadzu Corporation, Waters Corporation, HTG Molecular Diagnostics Inc., Bio-Rad Laboratories Inc., PerkinElmer Inc., Bruker Corporation, Becton Dickinson & Company, and Merck KGaA